Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1062 GI-102, a novel CD80-IgG4-IL2v3 fusion protein driving lymphocyte expansion and anti-cancer potential through regulation of immune cells in the tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.
